No products in the cart.
Roll over image to zoom in
MOFETYL 500MG TABLET
₹388.00₹775.60 (-50%)
Mofetyl 500mg Tablet can be described as an immunosuppressant containing an active ingredient named Mycophenolate mofetil. It is part of the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop organ rejection in people who have had the organs of a donor (such as heart, kidney, or liver transplantation). It is usually prescribed as a part of a combination treatment, which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage or congenital disabilities. It is not recommended during pregnancy unless there are no other alternatives and the possible advantages outweigh the risks. Women who are pregnant should take effective contraception when using this tablet to prevent the onset of pregnancy. Live vaccines shouldn’t be administered while a patient is taking a Mofetyl 500mg Tablet because of the decreased vaccine effectiveness and the possibility of contracting infection. People taking this drug are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This will ensure that the medication is eliminated before blood donation.
It is usually advised not to use this medication when allergic to it or other ingredients. Inform your physician about heart or liver disease before beginning treatment. Since this medication weakens the body’s immune defenses, it could increase the risk of developing skin cancer. People should minimize their exposure to UV (UV) radiation. Consult your physician immediately in case of bruising on the skin, fever, unprovoked fatigue, dizziness, discoloration of the skin or eyes, vision impairment, decreased urinary output, or seizures following this medication. Mofetyl 500 mg Tablet is an anti-inflammatory medication. It could affect a baby’s developing immune system and should not be used while breastfeeding. In certain situations, alternatives to drugs that have an improved safety profile for breastfeeding can be thought of as.